Who owns LISATA THERAPEUTICS INC?
- Ticker: LSTA
- CUSIP Number: 128058302
Tip: Access positions for across all investors
Analyze quarterly positions in Lisata Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lisata Therapeutics stock
Who bought or sold LISATA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 285k | $888k | 5% | Mar 2024 |
|
| Vanguard Group | 182k | $567k | 3% | Mar 2024 |
|
| BlackRock | 56k | $175k | -1% | Mar 2024 |
|
| Geode Capital Management | 44k | $138k | 2% | Mar 2024 |
|
| Cook Wealth Management Group | 12k | $36k | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 12k | $37k | 100% | Mar 2024 |
|
| Susquehanna International | 11k | $33k | 100% | Mar 2024 |
|
| HighTower Advisors | 10k | $31k | 0% | Mar 2024 |
|
| Bank of America Corporation | 9.7k | $30k | 0% | Mar 2024 |
|
| Morgan Stanley | 2.6k | $8.0k | -18% | Mar 2024 |
|
| Tower Research Capital | 853.00 | $2.7k | 100% | Mar 2024 |
|
| Founders Capital Management | 333.00 | $1.0k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 54.00 | $168.112800 | 2% | Mar 2024 |
|
| Royal Bank of Canada | 52.00 | $0 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 16.00 | $50.000000 | 45% | Mar 2024 |
|
| Steward Partners Investment Advisory | 6.00 | $19.000200 | 0% | Mar 2024 |
|
| Barclays | 4.00 | $0 | 0% | Mar 2024 |
|
| Advisor Group Holdings | 1.00 | $3.000000 | 0% | Mar 2024 |
|
| UBS Group | 1.00 | $3.000000 | -100% | Mar 2024 |
|
Who sold out of Lisata Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Dec 2023 | 27k | $74k |
| Citadel Advisors | Dec 2023 | 14k | $39k |
| Northwestern Mutual Wealth Management Company | Sep 2023 | 20.00 | $43.000000 |
| IFP Advisors | Sep 2023 | 10.00 | $21.000000 |